Cellartis Xeno-Free GMP Grade Basal Medium
Cellartis Xeno-Free GMP Grade Basal Medium
Brand: Takara Bio.
In stock
SKU
Cellartis Xeno-Free GMP Grade Basal Medium
Cellartis DEF-CS 500 Xeno-Free GMP Grade Basal Medium is a chemically defined basal media that is free from human- and animal-derived components and is used for efficient expansion of undifferentiated human induced pluripotent stem (iPS) cells. Cellartis DEF-CS 500 Xeno-Free GMP Grade Basal Medium is manufactured as a quality-assured product, according to guidelines for Good Manufacturing Practice (GMP) for Investigational Products.
Overview
- Optimized for small- or large-scale production of pluripotent cells for downstream use in clinical research settings
- Manufactured as a quality-assured product, according to the guidelines for GMP for investigational products
- Rigorous manufacturing standards ensure quality and consistency; all materials are of clinical quality, with traceable production processes
The International Society for Pharmaceutical Engineering selected Takara’s Center for Gene and Cell Processing as the winner of its 2016 Facility of the Year Award (in the facility integration category)
The International Society for Pharmaceutical Engineering selected Takara’s Center for Gene and Cell Processing as the winner of its 2016 Facility of the Year Award (in the facility integration category). Its unique environment ensures product safety and was determined by the judges to be a practical, efficient model for future biopharmaceutical facilities.
Write Your Own Review
The International Society for Pharmaceutical Engineering selected Takara’s Center for Gene and Cell Processing as the winner of its 2016 Facility of the Year Award (in the facility integration category)
The International Society for Pharmaceutical Engineering selected Takara’s Center for Gene and Cell Processing as the winner of its 2016 Facility of the Year Award (in the facility integration category). Its unique environment ensures product safety and was determined by the judges to be a practical, efficient model for future biopharmaceutical facilities.
